Lipid deposition and metaflammation in diabetic kidney disease.
Curr Opin Pharmacol
; 55: 60-72, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-33137677
ABSTRACT
A critical link between metabolic disorders and a form of low-grade systemic and chronic inflammation has been recently established and named 'Metaflammation'. Metaflammation has been recognized as a key mediator of both microvascular and macrovascular complications of diabetes and as a significant contributor to the development of diabetic kidney disease (DKD). The goal of this review is to summarize the contribution of diabetes-induced inflammation and the related signaling pathways to diabetic complications, with a particular focus on how innate immunity and lipid metabolism influence each other.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetic Nephropathies
/
Lipid Metabolism
/
Inflammation
Limits:
Animals
/
Humans
Language:
En
Journal:
Curr Opin Pharmacol
Journal subject:
FARMACOLOGIA
Year:
2020
Document type:
Article